Went public 11/10/00 at $12 per share
Filing Range: 3.6 million shares @ $13 to $15
Share Outstanding: 19.37 million shares
Underwriters: Chase H&Q/CIBC World Markets/SG Cowen Securities
Company Counsel: Cooley Godward LLP
Manager Counsel: Stroock & Stroock & Lavan
Auditor: PricewaterhouseCoopers LLP
Develops and commercializes an innovative, patent-protected system for aerosolizing liquids into a highly uniform droplet size spray without pressure and with a very low cost nozzle and driver. The system will be applicable to a wide range of peptides, proteins and other macromolecules currently delivered by injection, as well as industrial and consumer product applications for its low cost, non-propellant-based aerosolizing technology.
U.S. Venture Partners
MF Private Capital
J.P. Morgan Capital Corp.
Viridian Capital Partners
Invesco Private Capital
Viridian Capital LLC
Hunt Ventures LP
Advent International Corp.
Advent Venture Partners
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 10/26/1994 4 Early Stage 1500.0
2 02/01/1996 4 Early Stage 3500.0
3 06/01/1997 4 Expansion 7495.0
4 08/03/1998 7 Later Stage 18000.1
5 03/01/2000 2 Expansion 10835.0
6 07/01/2000 8 Expansion 16870.8
(Data in $ millions)
Total Revenues: 0.5
Net Income: -9.0